Quest Patent Research (QPRC) 10-K 10 Apr 15 2013 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Apr. 09, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	QUEST PATENT RESEARCH CORP
Entity Central Index Key	824416
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Type	10-K
Document Period End Date	31-Dec-13
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2013
Entity Filer Category	Smaller Reporting Company
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	No
Entity Public Float			$1,517,285
Entity Common Stock, Shares Outstanding		263,038,334

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$159	$18,579
Investment in unconsolidated subsidiary	10,516
Accounts receivable	4,218	5,816
Accounts receivable - affiliates	5,295
Total current assets	20,188	24,395
Total Assets	20,188	24,395
Current liabilities:
Accounts payable and accrued expenses	75,407
Accrued officers' compensation	3,815,103	3,071,205
10% Loans payable - Officers/Director	79,490	79,490
10% Loans payable - third party	138,000	138,000
Accrued Interest	261,331	239,581
Total current liabilities	4,369,331	3,528,276
Total liabilities	4,369,331	3,528,276
Stockholders' Deficit:
Preferred Stock - Par Value $.00003 - authorized 10,000,000 Shares - no shares issued and outstanding
Common stock, par value $.00003; authorized 390,000,000 shares; shares issued and outstanding 233,038,334, for the years ended 2012, 2011, 2010, 2009 and 2008, respectively	6,991	6,991
Additional paid-in capital	9,572,279	9,551,279
Accumulated deficit	-13,931,134	-13,064,810
Total Quest Patent Research Corporation deficit	-4,351,864	-3,506,540
Non-controlling interest in subsidiary	2,721	2,659
Total stockholders' deficit	-4,349,143	3,503,881
Total liabilities and stockholders' deficit	$20,188	$24,395

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Statement of Financial Position [Abstract]
Loans Payable To Officer Interest Rate Stated Percentage	10.00%	10.00%
Loans Payable To Interest Rate Stated Percentage	10.00%	10.00%
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	390,000,000	390,000,000
Common stock, shares issued	233,038,334	233,038,334
Common stock, shares outstanding	233,038,334	233,038,334

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenues
Sales	$29,555	$43,475
Patent service fees	45,000	217,500
Total Revenue	74,555	260,975
Cost of goods sold:
Cost of sales	10,449	15,975
Royalties	11,617	61,564
Total Cost of Goods Sold	22,066	77,539
Gross profit	52,489	183,436
Operating expenses
Selling, general and administrative expenses	901,838	800,158
Total operating expenses	901,838	800,158
Loss from operations	-849,349	-616,722
Other expense
Interest expense	-21,750	-21,750
Total other expense	-21,750	-21,750
Net loss	-871,099	-638,472
Net loss attributable to non-controlling interest in subsidiaries	-62	-2,672
Net loss attributable to Quest Patent Research Corporation	($871,161)	($641,144)
Earnings (loss) per share Basic and Diluted	($0.00)	($0.00)
Weighted average shares outstanding - Basic and Diluted	233,038,334	233,038,334

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Stockholders' Equity (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]
Beginning Balance at Dec. 31, 2011	($3,503,881)	$6,991	$9,551,279	($12,423,666)	($13)
Begining balance, shere at Dec. 31, 2011		233,038,334
Net loss	-638,472			-641,144	2,672
Ending Balance at Dec. 31, 2012	3,503,881	6,991	9,551,279	-13,064,810	2,659
Begining balance, shere at Dec. 31, 2012		233,038,334
Deconsolidation of subsidiary	4,837			4,837
Compensation expense relating to warrants/options	21,000		21,000
Net loss	-871,099			-871,161	62
Ending Balance at Dec. 31, 2013	($4,349,143)	$6,991	$9,572,279	($13,931,134)	$2,721
Ending Balance, share at Dec. 31, 2013		233,038,334

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net loss	($871,161)	($641,144)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Deconsolidation of subsidiary	4,837
Earnings Attributable to Non-Controlling Interest	62	2,672
Share-based compensation	21,000
Changes in operating assets and liabilities
Accounts receivable	1,598	-4,341
Accounts receivable - affiliates	-5,295
Accrued officers compensation	743,898
Accounts payable and accrued expenses	97,157	619,150
Net cash used in operating activities	-7,904	-23,663
Cash flows from investing activities:
Cash sent to fund unconsolidated subsidiary	-10,516
Net cash used in investing activities	-10,516
Net decrease in cash and cash equivalents	-18,420	-23,663
Cash and cash equivalents at beginning of year	18,579	42,242
Cash and cash equivalents at end of year	159	18,579
Non Cash Financing Activities Accrued salary capital contribution

Description_of_Business_and_Ba

Description of Business and Basis of Presentation	12 Months Ended
	Dec. 31, 2013
Description of Business [Abstract]
DESCRIPTION OF BUSINESS	NOTE 1 – DESCRIPTION OF BUSINESS
	The Company is a Delaware corporation, incorporated on July 17, 1987 under the name Phase Out of America Inc. On September 24, 1997, the Company changed its name to Quest Products Corporation and on June 6, 2007, the Company changed its name to Quest Patent Research Corporation. During 2003, 2004, 2005, 2006 and 2007 the Company did not have any significant operations. The Company has been engaged in the intellectual property monetization business since 2008.
	As used herein, the “Company” refers to Quest Patent Research Corporation and its wholly and majority-owned and controlled operating subsidiaries unless the context indicates otherwise. All intellectual property acquisition, development, licensing and enforcement activities are conducted by the Company’s wholly and majority-owned and controlled operating subsidiaries.
	The Company is an intellectual property asset management company. Its principal operations include the development, acquisition, licensing and enforcement of intellectual property rights that are either owned or controlled by the Company. The Company currently owns, controls or manages five intellectual property portfolios, which principally consist of patent rights. As part of its intellectual property asset management activities and in the ordinary course of our business, it has been necessary for the Company or the intellectual property owner who the Company represents to initiate, and it is likely to continue to be necessary to initiate, patent infringement lawsuits and engage in patent infringement litigation. The Company anticipates that its primary source of revenue will come from the grant of licenses to use its intellectual property, including licenses granted as part of the settlement of patent infringement lawsuits. The Company also generates revenue from management fees for managing intellectual property portfolios.
	Intellectual property monetization includes the generation of revenue and proceeds from patents and patented technologies and other intellectual property rights. Patent litigation is often a necessary element of intellectual property monetization where a patent owner, or a representative of the patent owner, seeks to protect its patent rights against the unlicensed manufacture, sale, and use of the owner’s patent rights or products which incorporate the owner’s patent rights. In general, the Company seeks to monetize the bundle of rights granted by the patents through structured licensing and when necessary enforcement of those rights through litigation.
	The Company has rights to the following five intellectual property portfolios:
		●	Mobile Data, which relates to the automatic update of information delivered to a mobile device without the need for manual refreshing.
		●	Financial Data, which relates to universal financial data system which allows its holder to use the device to access one or more accounts stored in the memory of the device as a cash payment substitute as well as to keep track of financial and transaction records and data.
		●	Rich Media, which relates to methods, systems, and processes that permit typical Internet users to design rich-media production content (i.e., rich-media applications), such as websites.
		●	Von Kohorn, which relates to online couponing, print-at-home boarding passes and tickets, online sweepstakes; including the promotion by television networks of online sweepstakes.
		●	TurtlePakTM, which relates to a cost effective, high-protection packaging system recommended for fragile items weighing less than ten pounds.
	Through December 31, 2013, the Company did not generate any revenue from the Mobile Data and Financial Data portfolios. The revenues from the TurtlePakTM intellectual property are from the sale of products utilizing the technology.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of consolidation and financial statement presentation
	The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”) and present the consolidated financial statements of the Company and its wholly owned and majority owned subsidiaries as of December 31, 2013.
	The consolidated financial statements include the accounts and operations of:
	Quest Patent Research Corporation (“The Company”)
	Quest Licensing Corporation (1)
	Quest Packaging Solutions Corporation (90% owned)
	Quest Nettech Corporation (wholly owned)
		-1	Quest Licensing Corporation was a wholly owned subsidiary of the Company through October 31, 2012 when 50% of its issued and outstanding shares were transferred to Allied Standard Limited (see NOTE 1). Subsequent to October 31, 2012, the Company did not include Quest Licensing Corporation in its consolidated financial statements since there are significant contingencies related to the control of Quest Licensing Corporation.
	The operations of Wynn Technologies Inc. are not included in the Company’s consolidated financial statements as there are significant contingencies related to its control of Wynn Technologies Inc.
	The Company accounts for Quest Licensing Corporation and Wynn Technologies, Inc. under the equity method whereby the investment accounts are increased for contributions by the Company plus its 50% and 60% shares of income, respectively, and reduced for distributions and its 50% and 60% shares of loses incurred, respectively, with the restriction whereby the account balances cannot go below zero.
	Significant intercompany transaction and balances have been eliminated in consolidation.
	Pro Forma Financial Information (unaudited)
	The pro forma financial information set forth below is based upon our historical consolidated statements of operations for the years ended December 31, 2013 and 2012, adjusted to give effect to the deconsolidation of Quest Licensing as if it had occurred on January 1, 2012.
	The pro forma financial information is presented for informational purposes only and may not be indicative of what actual results of operations would have been had the deconsolidation occurred on January 1, 2012, nor does it purport to represent the results of future operations (in thousands):
			Year Ended
			31-Dec			31-Dec
			2013			2012
	Statement of operations:
	Revenue		$	74,555		$	260,975
	Cost of goods sold			22,066			77,539
	Gross profit			52,489			183,436
	Selling, general and administrative expenses			(901,838	)		(789,342	)
	Other expenses			(21,750	)		(21,750	)
	Net loss			(871,099	)		(627,656	)
	Net loss attributable to non-controlling interest in subsidiaries			(62	)		(2,672	)
	Net loss attributable to Quest Patent Research Corporation		$	(871,161	)	$	(630,328	)
	Use of Estimates
	In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturity dates of three months or less when purchased, to be cash equivalents.
	Accounts Receivable
	Accounts receivable are recorded at the invoiced amount. Any allowance for doubtful accounts is the Company’s best estimate of the amount of probable losses to the Company’s existing accounts receivable. No allowance for doubtful accounts was recorded for the year ended December 31, 2013.
	Intangible Assets
	Intangible assets consist of patents which are amortized using the straight-line method over their estimated useful lives or statutory lives whichever is shorter and are reviewed for impairment upon any triggering event that may give rise to the assets ultimate recoverability as prescribed under the guidance related to impairment of long-lived assets.
	Impairment of long-lived assets
	Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. Whenever any such impairment exists, an impairment loss will be recognized for the amount by which the carrying value exceeds the fair value.
	Fair value of financial instruments
	Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy is used which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
	The fair value hierarchy based on the three levels of inputs that may be used to measure fair value are as follows:
	Level 1 – Quoted prices in active markets for identical assets or liabilities.
	Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.
	The carrying value reflected in the consolidated balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short-term borrowings approximate fair value due to the short-term nature of these items.
	Revenue Recognition
	Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable and, (iv) the collectability of amounts is reasonable assured.
	License Service Fees
	In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is reasonably assured, or upon receipt of the minimum upfront fee for the term agreement renewals, and when all other revenue recognition criteria have been met.
	Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.
	Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.
	The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.
	Packaging Sales
	The Company’s packaging operation customers are end users. Revenues from packaging sales, less reserves for returns, are recognized upon shipment to the customer.
	Research and development
	Research and development costs are expensed as incurred.
	Income Taxes
	Deferred income tax assets and liabilities are recognized for the expected future income tax consequences of events that have been included in the consolidated financial statements or income tax returns. Deferred income tax assets and liabilities are determined based on differences between the financial statement and tax bases of assets and liabilities using tax rates in effect for the years in which the differences are expected to reverse.
	In evaluating the ultimate realization of deferred income tax assets, management considers whether it is more likely than not that the deferred income tax assets will be realized. Management establishes a valuation allowance if it is more likely than not that all or a portion of the deferred income tax assets will not be utilized. The ultimate realization of deferred income tax assets is dependent on the generation of future taxable income, which must occur prior to the expiration of the net operating loss carryforwards.
	The Company also follows the guidance related to accounting for income tax uncertainties effective November 1, 2007. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. No liability for unrecognized tax benefits was recorded as of December 31, 2013 and in the interim periods.
	Share-based compensation
	The Company accounts for share-based awards issued to employees and non-employees in accordance with Accounting Standards Codification (ASC) 718, “Compensation-Stock Compensation” effective February 1, 2006. Accordingly, employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period , which is normally the vesting period. Additionally, share-based awards to non-employees are expensed over the period in which the related services are rendered at their fair value.
	Prior to February 1, 2006 and as permitted by ASC 718, the Company accounted for their stock options in accordance with APB 25, “Accounting for Stock Issued to Employees.” Employee stock options are granted at or above the market price at dates of grant which does not require the Company to recognize any compensation expense.
	The Company adopted ASC 718 (then SFAS123R) on February 1, 2006 using the modified prospective method. In accordance with such method, the consolidated financial statements for prior periods have not been restated to reflect, and do not include, the impact of ASC 718.
	Earnings (loss) per share
Basic earnings per share is calculated by dividing net income available to common stockholders by the weighted average number of shares of the Company’s common stock outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if our share-based awards and convertible securities were exercised or converted into common stock. The dilutive effect of our share-based awards is computed using the treasury stock method, which assumes all share-based awards are exercised and the hypothetical proceeds from exercise are used to purchase common stock at the average market price during the period. The incremental shares (difference between shares assumed to be issued versus purchased), to the extent they would have been dilutive, are included in the denominator of the diluted earnings per share calculation. Because the Company incurred losses in all period covered by the financial statements, the diluted earnings per shares is the same as the basic earnings per share.
Concentration of credit risk
We maintain our cash in bank deposit accounts, which at times, may exceed federally insured limits. We have not experienced any such losses in these accounts.
Recently adopted accounting standards
Management does not anticipate that the recently issued but not yet effective accounting pronouncements will materially impact the Company’s financial condition.

Warrants_and_Stock_Options

Warrants and Stock Options	12 Months Ended
	Dec. 31, 2013
Warrants and Stock Options [Abstract]
WARRANTS AND STOCK OPTIONS	NOTE 3 – WARRANTS AND STOCK OPTIONS
	Warrants
	During March 2013, pursuant to the president’s employment agreement (see Note 7), the Company issued the president warrants to purchases 15,000,000 shares of common stock. The warrants vested immediately, have an exercise price of $0.004 and expire on March 1, 2018.
	The Company valued the warrants at $21,000 using the Black-Scholes pricing model. Variables used in the valuation include (1) discount rate of 0.77%; (2) warrant life of 5 years; (3) expected volatility of 548% and (4) zero expected dividends.
	During March 2010, the Company granted to its then chairman warrants to purchase 5,000,000 shares at a price of $0.004 per share, through March 1, 2015. The warrants expired unexercised.
	A summary of the status of the Company's stock warrants and changes is set forth below:
		Number of		Weighted		Weighted
		Warrants (#)		Average		Average
				Exercise		Remaining
				Price ($)		Contractual
						Life (Years)
	Balance - December 31, 2011		60,000,000		0.0038		5.8
	Granted		--
	Cancelled		--
	Expired		--
	Exercised		--
	Balance - December 31, 2012		60,000,000		0.0038		4.8
	Granted		15,000,000		0.004		5
	Cancelled		--
	Expired		--
	Exercised		--
	Balance - December 31, 2013		75,000,000		0.0038		3.9
	Warrants exercisable at end of year		75,000,000
	Weighted average fair value of warrants granted during period				0.0014
	Stock Options
	A summary of the status of the Company's stock options and changes is set forth below:
		Number of Options (#)		Weighted Average Exercise		Weighted Average Remaining Contractual Life (Years)
				Price ($)
	Balance - December 31, 2011		15,000,000		0.0045		2.33
	Granted		--
	Cancelled		--
	Expired		5,000,000
	Exercised		--
	Balance - December 31, 2012		10,000,000		0.00175		1.5
	Granted		--
	Cancelled		--
	Expired		5,000,000		0.0025		0.25
	Exercised		--
	Balance - December 31, 2013		5,000,000		0.001		1.75
	No warrants or options were exercised in 2013.

Noncontrolling_Interest

Non-controlling Interest	12 Months Ended
	Dec. 31, 2013
Non-controlling Interest [Abstract]
NON-CONTROLLING INTEREST	NOTE 4 – NON-CONTROLLING INTEREST
	The following table reconciles equity attributable to the non-controlling interest related to Quest Packaging Solutions Corporation.
		December 31,
		2013		2012
	Balance, beginning of year	$	2,659	$	(13	)
	Net income (loss) attributable to non-controlling interest	$	62	$	2,672
	Balance, end of year	$	2,721	$	2,659

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]
INCOME TAXES	NOTE 5 – INCOME TAXES
	The Company uses the liability method, where deferred tax assets and liabilities are determined based on the expected future tax consequences of temporary differences between the carrying amounts of assets and liabilities for financial and income tax reporting purposes. As of December 31, 2013, the Company has generated approximately $7,568,737 of net operating loss (“NOL”) carry forwards which will expire in the years 2019 through 2034. Internal Revenue Code section 382 (“Section 382”) restricts the use of these net operating losses in future periods if the Company has a “substantial change in ownership” as defined by Section 382. The Company has had significant equity transactions in both the current and prior periods. Due to this equity activity and the restrictions resulting under Section 382, most of the Company’s NOLs may not be available to offset future taxable income. The Company has fully reserved the deferred tax asset resulting from the net operating loss carry forwards.
	Deferred tax asset consisted primarily of the following:
		December 31,
		2013
	Net operating loss carry forward	$	3,027,200
	Valuation allowance	$	(3,027,200	)
	Total	$	-

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 6 – RELATED PARTY TRANSACTIONS
	Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.
	The Company has at various times entered into transactions with related parties, including officers, directors and major shareholders, wherein these parties have provided services, advanced or loaned money, or both, to the Company needed to support its daily operations. The Company discloses all related party transactions.
	During 2003, the Company received loans from Officers and Directors in the amount of $79,490. The loans are payable on demand plus accrued interest at 10% per annum.
	As of fiscal year ended December 31, 2013, the balance of Notes Payable to Related Parties was $79,490, and accrued interest on those notes was $89,594.
	See Notes 7 and 8 with respect to employment and termination agreements with officers and directors and the cancellation of debt to officers and directors.
	During 2013, the Company contracted with an entity owned by the chief technology officer for the provision of information technology services to the Company. In 2013, the cost of these services was approximately $1,500.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2013
Commitments [Abstract]
Commitments	NOTE 7 – COMMITMENTS
	On March 1, 2008, the Company entered into an employment agreement with its then chairman, pursuant to which the Company employed the chairman for a period of seven years, at an annual salary of $200,000. Pursuant to the employment agreement, the Company issued the chairman seven-year warrants to purchase an aggregate of 5,000,000 shares of common stock at an exercise price of $0.004 per share. The warrants vested upon the date of the execution of the employment agreement. See Note 8 with respect to the termination of the former chairman’s employment agreement.
	On March 1, 2008, the Company entered into an employment agreement with its then chief executive officer, who was also chief financial officer and treasurer, for a period of ten years for an annual salary of $250,000. The chief executive officer is eligible for an annual bonus of 10% of the Company’s consolidated income before taxes. Pursuant to the employment agreement, the Company issued him ten-year warrants to purchase 5,000,000 shares of common stock at $0.004 per share. The warrants vested upon the date of the execution of the employment agreement. The agreement provides that the Company will provide the chief executive officer with a full-size vehicle when it is financially able to do so, and a laptop computer and phone. The agreement also includes a severance provision whereby, if the Company terminates chief executive officer’s employment other than for cause, the Company is to pay the chairman severance compensation equal to three times his average annual compensation for the five years prior to termination and reimbursement of his COBRA expenses. See Note 8 with respect to the termination of the former chief executive officer’s employment agreement.
	On March 1, 2008, the Company entered into an employment agreement with our current president and chief executive officer who, at the time of the agreement, was its president and chief operating officer, for a period of ten years, subject to renewal, for an annual salary of $300,000. He is eligible for an annual bonus of 15% of consolidated income before taxes, as well as a contingent bonus of 20% of net income before taxes on the occurrence of certain events related to the Company’s assets, as established in the agreement. Pursuant to the agreement, the Company issued the president ten-year warrants to purchase 15,000,000 shares of common stock at an exercise price of $0.004 per share, which vested upon execution of the employment agreement, and agreed to issue to the president on the third anniversary of the date of execution of his employment agreement, seven-year warrants to purchase 30,000,000 shares of common stock at an exercise price of $0.004 per share, which the Company issued in 2011 and which vested on issuance, and the Company agreed to issue to the president on the fifth anniversary of the execution of his employment agreement, five-year warrants to purchase 15,000,000 shares of common stock at an exercise price of $0.004 per share, which the Company issued in 2013 and which vested on issuance. The agreement provides that the Company will provide the president with a full-size vehicle when it is financially able to do so, and a laptop computer and phone. The agreement also includes a severance provision whereby, if the Company terminates the president’s employment other than for cause, the Company is to pay severance compensation equal to three times his average annual compensation for the three years prior to termination and reimbursement of his COBRA expenses. See Note 8 with respect to an amendment and restatement of the president’s employment agreement.

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 8 – SUBSEQUENT EVENTS
	In March 2014, the Company entered in to contingent representation agreement with a law firm for representation on a structured licensing program, including litigation if necessary, for the Mobile Data Portfolio. Under the terms of the agreement, the law firm receives an agreed upon percentage of net recoveries as defined in the agreement. Through April 9, 2015, the Company did not realize any net recoveries from the Mobile Data Portfolio.
	In March 2014, the Company entered into a funding agreement whereby a third party agreed to provide funds to the Company to enable the Company to implement a structured licensing program, including litigation if necessary, for the Mobile Data Portfolio. Under the agreement, the third party receives an interest in the proceeds from the program, and the Company has no other obligation to the third party. Through March 8, 2015 the third party has provided funds in the amount of approximately $970,000 of which approximately $590,000 has been paid to litigation counsel and other third parties and $380,000 has been paid to the Company in conjunction with the litigation against parties which the Company believes are infringing on its intellectual property.
	In April 2014, the Company entered into an agreement with Allied Standard Limited, which holds an interest in the Quest Licensing Corporation, whereby Allied relinquished certain rights under the existing agreement, including its entitlement to a 50% interest in our Quest Licensing subsidiary, in exchange for the Company’s commitment to fund a structured licensing program for the Mobile Data Portfolio.
	On October 10, 2014, the Company entered into a separation agreement and mutual general release with its former chairmen whereby the former chairman forgave all loans, accrued interest, accrued salary, accrued benefits and released us from any claim to any compensation and benefits, accrued or otherwise, under any agreement or purported agreement, including his employment agreement dated March 1, 2008. The Company agreed that the former chairman would retain the warrants granted under the employment agreement dated March 1, 2008 and that the Company would pay the former chairman 3.25% of our net revenues, provided net revenues of the Company exceed $1,500,000, up to the aggregate amount of $250,000 with payments in any year not to exceed $125,000. All amounts owed to the former chairman under this agreement will be recorded as expense in the period in which they are earned. The total accrued compensation and other obligations waived by the former chairman was approximately $1,343,543. The warrants granted under the employment agreement dated March 1, 2008 expired unexercised on March 1, 2015.
	On October 10, 2014, the Company entered into a separation agreement and mutual general release with its former chief executive officer, who was chief financial officer and treasurer, whereby the former chief executive officer forgave all loans, accrued interest, accrued salary, accrued benefits and released the Company from any claim to any compensation and benefits, accrued or otherwise, under any agreement or purported agreement, including the employment agreement dated March 1, 2008, at any time between the former chief executive officer and the Company. The Company agreed that the former chief executive officer would retain the warrants granted under the employment agreement dated March 1, 2008 and that the Company would pay the former chief executive officer 3.25% of the Company’s net revenues, provided that its net revenues exceed $1,500,000, up to the aggregate amount of $700,000 with payments in any year not to exceed $300,000. All amounts owed to the former CEO under this agreement will be recorded as expense in the period in which they are earned. The total accrued compensation and other obligations waived by the former chief executive officer was approximately $1,667,350.
	On October 30, 2014, the Company entered into a restated employment agreement with its president and chief executive officer (who was formerly its president and chief operating officer), which was superseded by a restated employment agreement dated as of November 30, 2014. Pursuant to the restated employment agreement, the Company agreed to employ him as president and chief executive officer for a term of three years, commencing January 1, 2014, and continuing on a year-to-year basis unless terminated by either party on not less than 90 days’ notice prior to the expiration of the initial term or any one-year extension. The agreement provides for an annual salary of $252,000, which may be increased, but not decreased, by the board or the compensation committee. The chief executive officer is entitled to a bonus if the Company meets or exceeds performance criteria established by the compensation committee. The chief executive officer is also eligible to participate in any executive incentive plans which the Company may adopt. The Company also agreed to issue to the chief executive officer warrants to purchase 60,000,000 shares, representing the warrants that had been previously covered in his prior employment agreement but which had never been issued, and the Company issued to the chief executive officer a restricted stock grant for 30,000,000 shares which vested on January 15, 2015. As the 60,000,000 warrants were previously expensed when vested and still outstanding according to the old terms, this new issuance was deemed to have been a modification and any incremental expense in value will be expensed on the date of modification. The chief executive officer held the rights of a stockholder with respect to these shares, including the right to vote, subject to forfeiture in the event that the shares did not vest. In the event that the Company terminates the chief executive officer’s employment other than for cause or as a result of his death or disability, the Company will pay him severance equal to his salary for the balance of the term and, if he received a bonus for the previous year, an amount equal to that bonus, as well as continuation of his insurance benefits. The chief executive officer also waived accrued compensation of $1,167,705, representing his accrued salary for periods prior to January 1, 2014. The restated agreement also includes mutual releases between the chief executive officer and the Company.
	On November 21, 2014 the Company received a notice of allowance from the United States Patent and Trademark Office on US Patent Application 12/617,373, a continuation application in the Mobile Data Portfolio.
	In December 2014, settlements were reached with several defendants named by Quest NetTech in patent infringement suits brought against various entities in July 2014 in the U.S. District for the Eastern District of Texas. With respect to each defendant with whom settlement was reached, the parties entered into a mutual release.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]
Principles of consolidation and financial statement presentation	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of consolidation and financial statement presentation
	The consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”) and present the consolidated financial statements of the Company and its wholly owned and majority owned subsidiaries as of December 31, 2013.
	The consolidated financial statements include the accounts and operations of:
	Quest Patent Research Corporation (“The Company”)
	Quest Licensing Corporation (1)
	Quest Packaging Solutions Corporation (90% owned)
	Quest Nettech Corporation (wholly owned)
		-1	Quest Licensing Corporation was a wholly owned subsidiary of the Company through October 31, 2012 when 50% of its issued and outstanding shares were transferred to Allied Standard Limited (see NOTE 1). Subsequent to October 31, 2012, the Company did not include Quest Licensing Corporation in its consolidated financial statements since there are significant contingencies related to the control of Quest Licensing Corporation.
	The operations of Wynn Technologies Inc. are not included in the Company’s consolidated financial statements as there are significant contingencies related to its control of Wynn Technologies Inc.
	The Company accounts for Quest Licensing Corporation and Wynn Technologies, Inc. under the equity method whereby the investment accounts are increased for contributions by the Company plus its 50% and 60% shares of income, respectively, and reduced for distributions and its 50% and 60% shares of loses incurred, respectively, with the restriction whereby the account balances cannot go below zero.
	Significant intercompany transaction and balances have been eliminated in consolidation.
Pro Forma Financial Information (unaudited)	Pro Forma Financial Information (unaudited)
	The pro forma financial information set forth below is based upon our historical consolidated statements of operations for the years ended December 31, 2013 and 2012, adjusted to give effect to the deconsolidation of Quest Licensing as if it had occurred on January 1, 2012.
	The pro forma financial information is presented for informational purposes only and may not be indicative of what actual results of operations would have been had the deconsolidation occurred on January 1, 2012, nor does it purport to represent the results of future operations (in thousands):
			Year Ended
			31-Dec			31-Dec
			2013			2012
	Statement of operations:
	Revenue		$	74,555		$	260,975
	Cost of goods sold			22,066			77,539
	Gross profit			52,489			183,436
	Selling, general and administrative expenses			(901,838	)		(789,342	)
	Other expenses			(21,750	)		(21,750	)
	Net loss			(871,099	)		(627,656	)
	Net loss attributable to non-controlling interest in subsidiaries			(62	)		(2,672	)
	Net loss attributable to Quest Patent Research Corporation		$	(871,161	)	$	(630,328	)
Use of Estimates	Use of Estimates
	In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturity dates of three months or less when purchased, to be cash equivalents.
Accounts Receivable	Accounts Receivable
	Accounts receivable are recorded at the invoiced amount. Any allowance for doubtful accounts is the Company’s best estimate of the amount of probable losses to the Company’s existing accounts receivable. No allowance for doubtful accounts was recorded for the year ended December 31, 2013.
Intangible Assets	Intangible Assets
	Intangible assets consist of patents which are amortized using the straight-line method over their estimated useful lives or statutory lives whichever is shorter and are reviewed for impairment upon any triggering event that may give rise to the assets ultimate recoverability as prescribed under the guidance related to impairment of long-lived assets.
Impairment of long-lived assets	Impairment of long-lived assets
	Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable through the estimated undiscounted cash flows expected to result from the use and eventual disposition of the assets. Whenever any such impairment exists, an impairment loss will be recognized for the amount by which the carrying value exceeds the fair value.
Fair value of financial instruments	Fair value of financial instruments
	Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy is used which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.
	The fair value hierarchy based on the three levels of inputs that may be used to measure fair value are as follows:
	Level 1 – Quoted prices in active markets for identical assets or liabilities.
	Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation.
	The carrying value reflected in the consolidated balance sheets for cash and cash equivalents, accounts receivable, accounts payable and accrued expenses and short-term borrowings approximate fair value due to the short-term nature of these items.
Revenue Recognition	Revenue Recognition
	Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable and, (iv) the collectability of amounts is reasonable assured.
	License Service Fees
	In general, revenue arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined, relatively short period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for an additional minimum upfront payment. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the non-exclusive retroactive and future licenses, covenants-not-to-sue, releases, and other deliverables, including no express or implied obligation on the Company’s part to maintain or upgrade the technology, or provide future support or services. Generally, the agreements provide for the grant of the licenses, covenants-not-to-sue, releases, and other significant deliverables upon execution of the agreement, or upon receipt of the minimum upfront payment for term agreement renewals. As such, the earnings process is complete and revenue is recognized upon the execution of the agreement, when collectability is reasonably assured, or upon receipt of the minimum upfront fee for the term agreement renewals, and when all other revenue recognition criteria have been met.
	Certain of the Company’s revenue arrangements provide for future royalties or additional required payments based on future licensee activities. Additional royalties are recognized in revenue upon resolution of the related contingency provided that all revenue recognition criteria, as described above, have been met. Amounts of additional royalties due under these license agreements, if any, cannot be reasonably estimated by management.
	Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met.
	The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met, which is generally upon receipt of cash.
	Packaging Sales
	The Company’s packaging operation customers are end users. Revenues from packaging sales, less reserves for returns, are recognized upon shipment to the customer.
Research and development	Research and development
	Research and development costs are expensed as incurred.
Income Taxes	Income Taxes
	Deferred income tax assets and liabilities are recognized for the expected future income tax consequences of events that have been included in the consolidated financial statements or income tax returns. Deferred income tax assets and liabilities are determined based on differences between the financial statement and tax bases of assets and liabilities using tax rates in effect for the years in which the differences are expected to reverse.
	In evaluating the ultimate realization of deferred income tax assets, management considers whether it is more likely than not that the deferred income tax assets will be realized. Management establishes a valuation allowance if it is more likely than not that all or a portion of the deferred income tax assets will not be utilized. The ultimate realization of deferred income tax assets is dependent on the generation of future taxable income, which must occur prior to the expiration of the net operating loss carryforwards.
	The Company also follows the guidance related to accounting for income tax uncertainties effective November 1, 2007. In accounting for uncertainty in income taxes, the Company recognizes the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more likely than not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant tax authority. No liability for unrecognized tax benefits was recorded as of December 31, 2013 and in the interim periods.
Share-based compensation	Share-based compensation
	The Company accounts for share-based awards issued to employees and non-employees in accordance with Accounting Standards Codification (ASC) 718, “Compensation-Stock Compensation” effective February 1, 2006. Accordingly, employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period , which is normally the vesting period. Additionally, share-based awards to non-employees are expensed over the period in which the related services are rendered at their fair value.
	Prior to February 1, 2006 and as permitted by ASC 718, the Company accounted for their stock options in accordance with APB 25, “Accounting for Stock Issued to Employees.” Employee stock options are granted at or above the market price at dates of grant which does not require the Company to recognize any compensation expense.
	The Company adopted ASC 718 (then SFAS123R) on February 1, 2006 using the modified prospective method. In accordance with such method, the consolidated financial statements for prior periods have not been restated to reflect, and do not include, the impact of ASC 718.
Earnings (loss) per share	Earnings (loss) per share
	Basic earnings per share is calculated by dividing net income available to common stockholders by the weighted average number of shares of the Company’s common stock outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if our share-based awards and convertible securities were exercised or converted into common stock. The dilutive effect of our share-based awards is computed using the treasury stock method, which assumes all share-based awards are exercised and the hypothetical proceeds from exercise are used to purchase common stock at the average market price during the period. The incremental shares (difference between shares assumed to be issued versus purchased), to the extent they would have been dilutive, are included in the denominator of the diluted earnings per share calculation. Because the Company incurred losses in all period covered by the financial statements, the diluted earnings per shares is the same as the basic earnings per share.
Concentration of credit risk	Concentration of credit risk
	We maintain our cash in bank deposit accounts, which at times, may exceed federally insured limits. We have not experienced any such losses in these accounts.
Recently adopted accounting standards	Recently adopted accounting standards
	Management does not anticipate that the recently issued but not yet effective accounting pronouncements will materially impact the Company’s financial condition.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]
Sechedule of Pro Forma Financial Information (unaudited)		Year Ended
		31-Dec			31-Dec
		2013			2012
	Statement of operations:
	Revenue	$	74,555		$	260,975
	Cost of goods sold		22,066			77,539
	Gross profit		52,489			183,436
	Selling, general and administrative expenses		(901,838	)		(789,342	)
	Other expenses		(21,750	)		(21,750	)
	Net loss		(871,099	)		(627,656	)
	Net loss attributable to non-controlling interest in subsidiaries		(62	)		(2,672	)
	Net loss attributable to Quest Patent Research Corporation	$	(871,161	)	$	(630,328	)

Warrants_and_Stock_Options_Tab

Warrants and Stock Options (Tables)	12 Months Ended
	Dec. 31, 2013
Warrant [Member]
Schedule of outstanding stock warrants and options		Number of		Weighted		Weighted
		Warrants (#)		Average		Average
				Exercise		Remaining
				Price ($)		Contractual
						Life (Years)
	Balance - December 31, 2011		60,000,000		0.0038		5.8
	Granted		--
	Cancelled		--
	Expired		--
	Exercised		--
	Balance - December 31, 2012		60,000,000		0.0038		4.8
	Granted		15,000,000		0.004		5
	Cancelled		--
	Expired		--
	Exercised		--
	Balance - December 31, 2013		75,000,000		0.0038		3.9
	Warrants exercisable at end of year		75,000,000
	Weighted average fair value of warrants granted during period				0.0014
Option [Member]
Schedule of outstanding stock warrants and options		Number of Options (#)		Weighted Average Exercise		Weighted Average Remaining Contractual Life (Years)
				Price ($)
	Balance - December 31, 2011		15,000,000		0.0045		2.33
	Granted		--
	Cancelled		--
	Expired		5,000,000
	Exercised		--
	Balance - December 31, 2012		10,000,000		0.00175		1.5
	Granted		--
	Cancelled		--
	Expired		5,000,000		0.0025		0.25
	Exercised		--
	Balance - December 31, 2013		5,000,000		0.001		1.75

Noncontrolling_Interest_Tables

Non-controlling Interest (Tables)	12 Months Ended
	Dec. 31, 2013
Non-controlling Interest [Abstract]
Schedule of equity attributable to the non-controlling interest		December 31,
		2013		2012
	Balance, beginning of year	$	2,659	$	(13	)
	Net income (loss) attributable to non-controlling interest	$	62	$	2,672
	Balance, end of year	$	2,721	$	2,659

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Taxes [Abstract]
Schedule of Deferred Tax Assets		December 31,
		2013
	Net operating loss carry forward	$	3,027,200
	Valuation allowance	$	(3,027,200	)
	Total	$	-

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Statement of operations:
Revenues	$74,555	$260,975
Cost of goods sold	10,449	15,975
Gross profit	52,489	183,436
Selling, general and administrative expenses	901,838	800,158
Other expenses	-21,750	-21,750
Net loss	-871,099	-638,472
Net loss attributable to non-controlling interest in subsidiaries	62	2,672
Net loss	-871,161	-641,144
Pro Forma [Member]
Statement of operations:
Revenues	74,555	260,975
Cost of goods sold	22,066	77,539
Gross profit	52,489	183,436
Selling, general and administrative expenses	-901,838	-789,342
Other expenses	-21,750	-21,750
Net loss	-871,099	-627,656
Net loss attributable to non-controlling interest in subsidiaries	-62	-2,672
Net loss	($871,161)	($630,328)

Summary_of_Significant_Account4

Summary of Significant Accounting Policies (Details Textual)	12 Months Ended	1 Months Ended
	Dec. 31, 2013	Oct. 31, 2012
Summary Of Significant Accounting Policies (Textual)
Percentage of ultimate settlement with the relevant tax authority	50.00%
Quest Packaging Solutions Corporation [Member]
Summary Of Significant Accounting Policies (Textual)
Ownership percentage	90.00%
Allied Standard Limited [Member]
Summary Of Significant Accounting Policies (Textual)
Percentage of issued and outstanding shares		50.00%
Quest Licensing Corporation [Member]
Summary Of Significant Accounting Policies (Textual)
Contribution percentage	50.00%
Distribution percentage	50.00%
Wynn Technologies [Member]
Summary Of Significant Accounting Policies (Textual)
Contribution percentage	60.00%
Distribution percentage	60.00%

Warrants_and_Stock_Options_Det

Warrants and Stock Options (Details) (Warrant [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Mar. 01, 2015
Warrant [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Beginning Balance	60,000,000	60,000,000
Granted	15,000,000
Cancelled
Expired
Exercised
Ending Balance	75,000,000	60,000,000	60,000,000
Beginning Balance, Weighted Average Exercise Price	$0.00	$0.00		$0.00
Weighted Average Exercise Price, Granted	$0.00
Ending Balance, Weighted Average Exercise Price	$0.00	$0.00	$0.00	$0.00
Warrants exercisable at end of year	75,000,000
Weighted average fair value of warrants granted during period	$0.00
Beginning Balance, Weighted Average Remaining Contractual Life (Years)	3 years 10 months 24 days	4 years 9 months 18 days	5 years 9 months 18 days
Granted, Weighted Average Remaining Contractual Life (Years)	5 years

Warrants_and_Stock_Options_Det1

Warrants and Stock Options (Details 1) (Option [Member], USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Option [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Beginning Balance	10,000,000	15,000,000
Granted
Cancelled
Expired	5,000,000	5,000,000
Exercised
Ending Balance	5,000,000	10,000,000
Beginning Balance, Weighted Average Exercise Price	$0.00	$0.00
Ending Balance, Weighted Average Exercise Price	$0.00	$0.00
Weighted average exercise price, Expired	$0.00
Beginning Balance, Weighted Average Remaining Contractual Life (Years)	1 year 6 months	2 years 3 months 29 days
Weighted Average Remaining Contractual Life (Years)	3 months
Ending Balance, Weighted Average Remaining Contractual Life (Years)	1 year 9 months	1 year 6 months

Warrants_and_Stock_Options_Det2

Warrants and Stock Options (Details Textual) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2010	Mar. 31, 2008	Dec. 31, 2011
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Warrant & stock option amount	$21,000
Warrant [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Purchase of common shares			5,000,000
Exercise price	$0.00	$0.00			$0.00
Warrant & stock option amount	21,000
Discount Rate	0.77%
Warrant & option life	5 years
Expected Volatility Rate	548.00%
Warrant expected dividends	$0
Warrant [Member] | President [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Purchase of common shares	15,000,000			30,000,000
Exercise price	$0.00
Expiration Date	1-Mar-18

Noncontrolling_Interest_Detail

Non-controlling Interest (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Equity attributable to noncontrolling interest [Abstract]
Balance, beginning of year	$2,659	($13)
Net loss attributable to non-controlling interest in subsidiaries	62	2,672
Balance, end of year	$2,721	$2,659

Income_Taxes_Details

Income Taxes (Details) (USD $)	Dec. 31, 2013
Income Taxes [Abstract]
Net operating loss carry forward	$3,027,200
Valuation allowance	-3,027,200
Total

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	Dec. 31, 2013
Income Taxes [Abstract]
Net operating loss	$7,568,737

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2003
Related Party Transactions (Textual)
Notes payable to related parties	$79,490
Accrued interest	89,594
Provision of information technology services	1,500
Officers and Directors [Member]
Related Party Transactions (Textual)
Loan received from officers and directors		$79,490
Percentage of loans payable		10.00%

Commitments_Details

Commitments (Details) (USD $)	1 Months Ended
	Mar. 31, 2008
Chairman
Commitments (Textual)
Term of agreement	7 years
Annual salary	$200,000
Chairman | Seven Year Warrant [Member]
Commitments (Textual)
Warrants issued to purchase of Common Stock	5,000,000
Excercise price	$0.00
Chief Executive Officer [Member]
Commitments (Textual)
Term of agreement	10 years
Annual salary	250,000
Annual bonus	10.00%
Chief Executive Officer [Member] | Ten Year Warrant [Member]
Commitments (Textual)
Warrants issued to purchase of Common Stock	5,000,000
Excercise price	$0.00
President & Cheif operating officer [Member]
Commitments (Textual)
Term of agreement	10 years
Annual salary	$300,000
Annual bonus	15.00%
Contingent bonus	20.00%
President & Cheif operating officer [Member] | Seven Year Warrant [Member]
Commitments (Textual)
Warrants issued to purchase of Common Stock	30,000,000
Excercise price	$0.00
President & Cheif operating officer [Member] | Ten Year Warrant [Member]
Commitments (Textual)
Warrants issued to purchase of Common Stock	15,000,000
Excercise price	$0.00
President & Cheif operating officer [Member] | Five Year Warrant [Member]
Commitments (Textual)
Warrants issued to purchase of Common Stock	15,000,000
Excercise price	$0.00

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	1 Months Ended	12 Months Ended	1 Months Ended		0 Months Ended
	Mar. 31, 2008	Dec. 31, 2013	Mar. 31, 2014	Oct. 30, 2014	Oct. 10, 2014	Apr. 30, 2014
Chief Executive Officer [Member]
Subsequent Event [Line Items]
Annual bonus	10.00%
Annual salary	$250,000
Term of agreement	10 years
President [Member]
Subsequent Event [Line Items]
Annual bonus	15.00%
Annual salary	300,000
Term of agreement	10 years
Warrant [Member] | President [Member]
Subsequent Event [Line Items]
Vesting period		1-Mar-18
Subsequent Event [Member]
Subsequent Event [Line Items]
Funds provided by third party			970,000
Litigation fees			590,000
Litigation expense pertaining to intellectual property			380,000
Subsequent Event [Member] | Allied Standard Limited [Member]
Subsequent Event [Line Items]
Ownership percentage						50.00%
Subsequent Event [Member] | President [Member]
Subsequent Event [Line Items]
Term of agreement				3 years
Subsequent Event [Member] | Warrant [Member] | Chief Executive Officer [Member]
Subsequent Event [Line Items]
Warrants issued				60,000,000
Annual salary				252,000
Total accrued compensation and other obligations				1,167,705
Term of agreement				3 years
Restricted stock granted				30,000,000
Vesting period				15-Jan-15
Description of agreement				Pursuant to the restated employment agreement, the Company agreed to employ the chief executive officer as president and chief executive officer for a term of three years, commencing January 1, 2014, and continuing on a year-to-year basis unless terminated by either party on not less than 90 days' notice prior to the expiration of the initial term or any one-year extension.
Subsequent Event [Member] | Warrant [Member] | Former Chairman [Member]
Subsequent Event [Line Items]
Annual bonus					3.25%
Deferred compensation arrangement cash award granted					1,500,000
Annual salary					250,000
Deferred compensation arrangement individual maximum payments					125,000
Total accrued compensation and other obligations					1,343,543
Subsequent Event [Member] | Warrant [Member] | Former Chief Executive Officer [Member]
Subsequent Event [Line Items]
Annual bonus					3.25%
Deferred compensation arrangement cash award granted					1,500,000
Annual salary					700,000
Deferred compensation arrangement individual maximum payments					300,000
Total accrued compensation and other obligations					$1,667,350